NICE on lipid modification

NICE’s simplified approach to lipids will not work

BMJ 2008; 336 doi: 10.1136/bmj.39605.513889.3A (Published 12 June 2008)
Cite this as: BMJ 2008;336:1324.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Stuart J Laurie, general practitioner
  1. 1Long Lane Medical Centre, Liverpool L9 6DQ
  1. stuart.laurie{at}livgp.nhs.uk

    Although starting all patients on simvastatin 40 mg for secondary prevention is a sound approach for many,1 a substantial proportion will not achieve the targets of less than 4 mmol/l for total cholesterol and 2 mmol/l for low density lipoprotein (LDL) cholesterol with this …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL